Dade adds plasma-protein to Premier deal:
This article was originally published in Clinica
Executive Summary
Dade Behring and Premier, the US hospital buying group, have agreed to add the instruments and assays for plasma-protein testing to their clinical chemistry contract, signed last year. The quantitative automated nephelometry tests can diagnose and monitor various disease states, including cardiovascular risk, rheumatic, chronic and acute inflammatory diseases, renal function and iron metabolism.